从含铜的水凝中提供局部性普拉诺洛尔,以通过上腺体β受体阻塞来增强受感染烧伤的愈合
Wenzhe Sun1, Hongwei Lu1, Pengqin Zhang1
1Department of Orthopaedics, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei Province, China.
Materials today. Bio
|February 3, 2025
概括
这项研究开发了一种新的水凝,将铜离子和醇结合起来,用于治疗受感染的烧伤. 水凝通过对抗细菌,促进血管生长和抵消压力反应来加速愈合.
科学领域:
- 生物材料科学 生物材料科学
- 组织工程是组织工程.
- 伤口治愈研究研究 伤口治愈研究
背景情况:
- 严重的烧伤会诱导全身应激反应,释放甲醇胺,通过β-上腺素受体 (β-AR) 损害皮肤再生.
- 细菌感染使烧伤治疗复杂化,在临床管理中提出了重大挑战.
- 现有的治疗方法往往无法解决烧伤的复杂神经调节环境.
研究的目的:
- 开发一种新的水凝系统,通过准神经微环境来治疗受感染的烧伤.
- 研究铜离子 (Cu2+) 和醇在促进烧伤修复方面的协同作用.
主要方法:
- 开发一种与铜离子交联的propranolol@gelatin/alginate水凝 (PNL@GA-Cu),用于局部输送.
- 对水凝对黄金葡萄球菌和大肠杆菌的抗菌活性的评估.
- 在体外和体内对Cu2+和propranolol对血管生成和交感神经调节的影响的评估.
- 在Sprague-Dawley大鼠的第三度全厚烧伤模型中测试水凝的有效性.
主要成果:
- PNL@GA-Cu水凝表现出有效的抗菌活性,并通过上调CD31和VEGF表达来促进血管生成.
- 水凝中的普罗普兰诺洛尔抵消了因诺阿皮内林诱导的血管生成抑制,并减少了交感内置.
- 水凝显著加速了大鼠的三度全厚烧伤的修复.
- 这项研究是第一个在烧伤治疗中解决神经微环境的研究.
结论:
- 开发的抗同情性PNL@GA-Cu水凝是一种治疗受感染烧伤的有希望的策略.
- 同时释放的Cu2+和propranolol协同增强了伤口愈合.
- 调节神经调节微环境代表了再生医学组织工程的新有效方法.
相关概念视频
01:16Antianginal Drugs: Nitrates and β-Blockers
509
In cardiovascular health, antianginal drugs combat angina pectoris — a condition marked by chest pain owing to diminished blood flow to the heart.
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow....
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow....
509
01:22Drug Delivery: Miscellaneous Routes
305
Drug delivery methods like oral inhalation, nasal sprays, transdermal patches, eye drops, intravitreal injection, and rectal administration provide localized effects with reduced toxicity.
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs...
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs...
305
01:31Adrenergic Antagonists: ɑ and β-Receptor Blockers
404
Third-generation β-blockers, such as labetalol and carvedilol, represent a significant advancement in managing cardiovascular conditions. Unlike conventional β-blockers, which can induce peripheral vasoconstriction, third-generation drugs block α1 adrenoceptors. This promotes vasodilation through several mechanisms, such as increased nitric oxide production, inhibition of calcium ion entry, opening of potassium ion channels, and antioxidant action. Labetalol, for instance, is...
404
01:23Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
146
Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
146